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Disclaimer report  
This report is the first document to describe our focus group investigation and in-
depth interviews in order to gain insight in the attitudes, (non-)communication and 
knowledge of our non-European patients regarding living donor kidney 
transplantation. The report is a detailed description of our investigation and was made 
directly after the data collection, in order to allow fast communication between 
researchers and/or clinicians. As such, this report provides technical details about the 
methodology and extensive tables of the data.  
  Although the report will probably remain the most detailed description of our 
research effort, it must not be seen as the final interpretation of the results. The report 
will serves as an easy referable and accessible collection of the (almost) raw research 
data, on which basis we hope to write peer-reviewed articles. This original report will 
remain available on request, for those researchers who would like to have a detailed 
description of our first research steps and the accompanying data. Note that parts of 
the report still reveal our early thoughts and interpretations, which are characteristic 




Development of the Rotterdam Renal Replacement Knowledge-
Test (R3K-T) 
 
S.Y. Ismail1, E.K. Massey2, A. Luchtenburg2, L. Timmerman2, W. Zuidema2, W. 
Weimar2, J.J. van Busschbach1.  
 
Depts. of Medical Psychology and Psychotherapy1, Erasmus Medical Centre 
Rotterdam and Internal Medicine2, Erasmus Medical Centre Rotterdam, the 
Netherlands. 
 
Introduction: There is currently a lack of validated or standardized measures to test 
the level of knowledge among renal patients regarding kidney disease and available 
treatment options. We conducted a pilot study to develop a questionnaire measuring 
knowledge of kidney disease, dialysis and transplantation options. The main aim of 
this study was to develop such an instrument for further use in research and practice. 
Method: An initial 61 item pool was generating by searching the literature and 
consulting experts in this area for additional items. This questionnaire was completed 
by 182 renal disease patients from 4 dialysis centers in the Rotterdam municipality. A 
factor analysis was conducted using the maximum likelihood factor method followed 
by direct oblimin rotation to obtain variance explained by each factor. Questions that 
loaded ≥ .30 on a factor were included. 
Results: Twenty-seven patients (24%) were in the pre-RRT phase, 60 (54%) were 
undergoing haemodialysis, 16 (14%) were undergoing peritoneal dialysis, and 9 (8%) 
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had a graft failure. Forty (36%) were female and 72 (64%) were male. Age range 19-
87 (median = 59). A factor analysis was conducted to reduce the number of items. 
This resulted in 30 items consisting of 5 subscales regarding knowledge on: kidney 
disease (5 items, α = .37), peritoneal dialysis (4 items, α = .73), haemodialysis (4 
items, α = .41), kidney transplantation (12 items, α = .86), quality of life (5 items, α = 
.59). 
Discussion: This study aimed to develop an instrument with which knowledge of 
kidney disease and the related treatment options can be reliably measured. This study 
resulted in a short and easy to administer knowledge questionnaire. We intend to 
further explore the psychometric properties of this instrument and develop norm 
scores for the general public and patients at various stages of the disease and 
treatment. We have also considered translated versions of this questionnaire.  
 





Knowledge can be seen as one of the strongest motivators for promoting 
adherence and for making well-informed decisions (Kumar, Shaikh, Khalid, & 
Masood, 2010). In order to support informed decision making we need to recognize 
possible gaps in their knowledge. If we look into decision making in other chronic 
diseases such as cancer one can see that knowledge can be considered as one of the 
strongest motivators for promoting adherence and for making well-informed decisions 
(Kumar, et al., 2010). Before we start developing interventions and other procedures 
to improve the level of knowledge in kidney patients, it is important to have an 
instrument to capture their current state of knowledge regarding their disease. This is 
necessary in order to identify gaps in knowledge and to test the efficacy of 
educational efforts. Consequently, this would provide clinicians and policy makers a 
reference point from which they could constitute a tailored program to educate their 
patients. There is currently a lack of validated and standardized measures to test the 
level of knowledge among renal patients regarding kidney disease and available 
treatment options. The main aim therefore of this study was to develop and validate 
such an instrument for further use in research and practice.  
 
Method 
We searched the literature for questionnaires measuring knowledge on renal 
replacement therapy (RRT). This resulted in 2 measures (Devins, et al., 1990; 
Rodrigue, Cornell, Lin, Kaplan, & Howard, 2007; Stothers, 2004). We expanded with 
consulting experts in this area for additional items (e.g. nephrologists, transplant 
coordinators, social workers). The result was a pool of 61 items of closed multiple-
choice questions (see Appendix A). In order to avoid the possibility of patients 
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responding without knowing the answer, the last response category for all questions 
was ‘‘I don’t know’’. We conducted a pilot study to investigate the content validity of 
this questionnaire namely, measuring knowledge of kidney disease, dialysis and 
transplantation options. Content validity is a judgement whether an instrument 
captures the relevant or important content or domains (Steiner & Norman, 1995). To 
examine content validity, we performed an exploratory factor analysis (Thompson, 
2004). This process was refined with reviews from experts. Following this dual 
selective process, some items regarded as inappropriate were removed from the 
questionnaire, other items were reformulated for enhanced clarity and precision. To 
ensure face validity pre-test patients (N=6) were asked to comment on the 
questionnaire regarding certain problems associated with the questionnaire such as, 
problems with the formulation of the questions, relevance and appropriateness of the 
responses. Based on this information, the questionnaire was adapted.  
 
Patients 
This pilot study was conducted among 182 patients of four different clinics in 
the Rotterdam municipality. Patients were either in the pre-RRT phase (24%), being 
treated with haemodialysis (54%), peritoneal dialysis (14%), had a graft failure (8%). 
64% Male; 36% Female. Age range 19-87 (median = 59). Inclusion criterion was 
being able to understand the Dutch language sufficiently. When reading (Dutch) was 
compromised/limited, the questionnaire was conducted verbally. Another criterion 
was being cognitively and physically capable of filling out the questionnaire 






After that, factor analysis was applied to the 61 items of the questionnaire. The 
maximum likelihood factor method was followed by direct oblimin rotation by which 
we allowed factors to be correlated or oblique to one another. Eigenvalues represent 
the variance explained by each factor, and the proportion of variance explained by 
each factor is the eigenvalue for this factor divided by the sum of all eigenvalues 
(Kaiser-Guttman criterion). The number of factors chosen for the direct oblumin 
rotation was based on the number of factors with an eigenvalue >1, because factors 
with eigenvalues greater than 1 explain more variance than any single (scaled) 
question. Since the Kaiser criterion may retain too many factors when there are many 
variables we also looked at the scree test, which essentially looks for a marked break 
between the initial big factors that explain the largest proportion of the variance and 
the later smaller factors that explain very similar and small proportion of the variance 
(Cattell, 1966). Significant loading of questions on the factors was defined as >0.30. 
Factor labels (i.e. content) were determined on the basis of the questions with the 
largest significant loadings on those factors. Finally we also explored the internal 
consistency reliability, which is the degree to which the items of the instrument are 
related to each other (Steiner & Norman, 1995). This was determined on the basis of 
the Cronbach α of the 61 items. A value >0.70 was considered to show adequate 
internal consistency reliability. 
 
Results 
The following factors were determined following this line of data-analysis: 
kidney disease (5 items, α = .56), peritoneal dialysis (4 items, α = .73), haemodialysis 
(4 items, α = .38), kidney transplantation (12 items, α = .86) and quality of life (5 
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items, α = .57). Cronbach’s α was .81 for all patients. Our results demonstrated good 
internal consistency reliability and content validity for the 30 item questionnaire 
which we named the Rotterdam Renal Replacement Knowledge-Test (R3K-T) (see 




Our next step is to further explore the psychometric properties of the R3K-T, 
including reliability, validity, sensitivity, and the minimally important difference 
(MID; i.e. clinically significant change) for evaluating disease-specific knowledge in 
renal end-stage patients during the different stages of their disease process. 
Additionally we need to do some confirmative or unidemtionality tests to validate the 
factor-structure reavealed in this exploratory phase. The long-term purpose of the 
R3K-T would preferably be to discriminate between well-informed and poorly 
informed patients regarding their disease and the concurrent treatment options.  
We would like to assess and validate this questionnaire in different groups of 
respondents, to be able to create a continuous scale along which patients can have a 
score which would represent their level of knowledge. This would lead to a clinical 
interpretation of advocating patients to appropriate (tailored) education programs in 
concordance with their score on the R3K-T. In order to create such a continuous scale 
one would preferably validate the questionnaire in different groups which are in 
different stages of the disease-specific knowledge process. Appropriate groups for 
constituting such a scale would be the general population (naïve group), the pre-
emptive patients, patients on dialysis, post-transplantation patients, potential donors 
and donors.  
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For international usage of the R3K-T we would also recommend to validate 
the questionnaire in the USA. The USA has the advantage of providing us with data 
from respondents form a wide range of cultural backgrounds. This adding would 
broaden the clinical applicability of the questionnaire enormously. Secondly, 
researchers would also benefit from being able to compare their work when this 
instrument is internationally used in different studies. 
 
Translations  
As in other Western countries, the number of immigrants in the Netherlands is 
growing rapidly. In 1980 non-western immigrants constituted about 3% of the 
population, in 1990 it was 6% and currently it is more than 10%. Nearly half of the 
migrant population lives in the four major cities. In the municipality of Rotterdam 
38% of the inhabitants are migrants (Roodnat, et al., 2010). Health policy is based on 
the ideal that all inhabitants should have equal access to information with respect to 
their condition. Following this, information in our outpatient transplantation clinic 
regarding the transplantation procedures is provided in Dutch only. However we 
know from several reviews that linguistic barriers at patient level are one of the most 
prominent culture-related communication problems (Uiters, Deville, Foets, & 
Groenewegen, 2006). Since we have now developed a questionnaire measuring the 
gap in knowledge it would consequently follow to make this instrument also 
accessible for the ethnically diverse populations. Thus, we need to create translated 
versions of the R3K-T. We decided to investigate which languages were spoken by 
our patients and to what degree they needed a translated version of material related to 
patient-education.  Therefore, we have conducted a study with an open cohort design. 
We registered the mother tongue, ethnicity, country of birth, the ability to understand 
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or speak Dutch, age and living area of all new patients that visited the transplantation 
outpatient clinic of the Erasmus Medical Centre in Rotterdam (Erasmus MC) for the 
last four years. 
We found that 39.8% of our patients without a potential living donor are non-
Caucasian. Of this population 32.8% had a mother tongue different than the language 
of the country of residence, thereby composing 22 different languages of which 16 are 
non-European. We also looked at the percentage of the linguistically different patients 
who did neither understand nor spoke the Dutch language. This turned out to be 
18.2%. These patients spoke Turkish (15.2%), Arabic (12.7%), Papiamento (8.9%), 
Portuguese (6.2%), and Modern Hindi (5.7%). The other languages were represented 
at percentages which are economically less interesting to disseminate translations for 
(1.3% to 3.8%).  
These findings demonstrate that there is a substantial linguistic diversity 
within our patients in the kidney transplantation clinic. These differences may 
decrease in the future when the proportion of first-generation immigrants decreases. 
For now, in the face of the equity principle, we have considered to provide the 
required questionnaires and information also in the major non-European languages in 
order to equalize the health care accessibility with regard to kidney transplantation. 
We present below the translated versions of the R3K-T in Appendix C (Turkish 
version), Appendix D (Arabic version), Appendix E (Papiamento version), Appendix 
F (Portuguese version), and Appendix G (Modern Hindi version). Since Frensh is a 
common spoken language in the world we have additionally translated the R3KT-T in 
this language (Appendix H). Lastly, considering the fact that the R3K-T is developd 
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Primary questionnaire used for the pilot study (the questions in italic/bleu are the 




















































































































































































































































































































































































































































































































































































































































































































































































































































































 cibarA otni gnitalsnart dna gnitros modnar dna noitcuder-atad retfa T-K3R ehT
 
 (R3K‐T)  بروتردام معرفة الكلي علىلأسئلة احةئلا
 
 ابغنا لأسئلةبهاذ ا. لتبديل وضيفة الكلي لى مرض الكلي و علي اشكال مختلفة اديال العلاج البحث يتحدث عهذا
 .نعرف شحال آتعرف على مرض الكلي والعلاج
 
 على الاجوبة باش اتكون عندنا ما اتقمرشنطلبو منك .   د قيقة01ة ما يتعداش سئللاا حةئلا هذالتعمار اديال 
 .  نظرة باين
 .ة صعبةسئلة سهلة و اسئل و فيها امعقدةة سئللاا حةئلا هذ. اختار منعرف,  على الجواب دتأآالى ما راآش م
 
 نعفرفو اشىنى باقي ما تعرفش عليه باش ه الطريقةبهاذ. لاجويةامهيم هو اتعمر اشنو عارف وما اتقلبش على 
 .نعطبو لك عليه المعلومات
 
 :مثال
 الانسان عند جوج آليات  
 صحيح (d)
  خطا (e)
  منعرف (f)
 
 
  . الى ماعرفتش واش صحيح او خطا عمار منعرف. ا المثل صحيح او خطاهذلان عمر واش ا
 .aالجواب الصحيح هو 
 





















    .4
 اديال النهائيةغسل البطن هو شكل ديال غسل الكليات و علاج لي المرض الكلي في المرحلة  
   ؟ العلاج ممكنهذاواش من جهة في الجسم آتجعل . المرض الكليات















































 لي يقدر اآون تبديل لي غسل  العلاج  هو شكل ديال)esylaid laaenotireP(غسل البطن   .21
  :الميزة  تقدر اتكون  )esylaidomeH(.الكليات
 
 المريض يقدر يتمشى في الوقت لي اآون يتغسل فيه البطن (a)  
 اخصها تندار غير مرة واحدة في الاسبوع (b)
 ما اخصش تندار العملي من قبل (c)
 منعرف (d)
 


















  )esylaid(  قبل ما يبدا العلاج,اخصهوم يتزولو,الى آان الانسان مريض بالكليات    .61
 









 وشنو آيوقع بالسائل من .في البطن)retehtak( بالقسطرة  سائل آيدخل , من اآون البطن يتغسل   .81
 بعد؟
 
 من بعد ساعات من الوقت آيتطلق ,سائل آيبق في البطنال (a)  
 ائل آيبق في البطن حتى يتسرب من قبل الجسمسال (b)
 ائل آيدخل في الكلي المصطنعة عبر قسطرة اخرىاالس (c)















  مستمر  (c)
 منعرف (d)
 





   : ادوا اديال المناعة آيتعطى لي المرضى اللي تزرعت لهم الكلي على احسب   .6
 
 يال الكلي الجديدة و العلاج اديال المناعة ادالوقاية  (a)  
 . اديال الكلي الجديدتجلط الدم العلاج اديال  (b)
 بكتيريا حماية الكلي ضد العدوى من قبل فيروس او  (c)
  منعرف (d)
 
 ؟ اش من علاج يعطي افضل جودة للحياة   .7
 
  )esylaidomeH( ي غسل الكل (a)  
 زرع (b)
 )esylaid laaenotireP(غسل البطن  (c)
 منعرف (d)
 
هذا واحد من المشاآل الكبيرة عند . غشاء البطن اديال و عدوى ه)sitinotireP(التهاب الصفاق   .8


































































































































































































































































































































































































































































































































































































































































































































































































































































The R3K-T after data-reduction and random sorting and translating into French 
Connaissance a propos des maladies rénales, dialyse et transplantation 
 
Avec les questions suivantes nous voulons savoir votre dégrée de connaissance 
des maladies rénales et leur traitements. Si vous connaissez pas la réponse cochez 













































































































































































































































The R3K-T after data-reduction and random sorting and translating into Dutch 
Rotterdam Renal Replacement Knowledge‐Test (R3K‐T) 
 
Deze vragenlijst gaat over nierziekten en de verschillende vormen van 
nierfunctievervangende behandelingen. Met deze vragen willen wij een indruk krijgen van 
de mate waarin u bekend bent met nierziekte en de behandelingen.  
 
Het invullen zal niet meer dan 10 minuten in beslag nemen. Om een goed beeld te krijgen, 
willen we u vragen om niet te gokken. Als u niet zeker van uw antwoord bent, kruis dan 
‘weet ik niet’ aan.  
 
Belangrijk is dat u de antwoorden niet op zoekt, maar echt invult wat u weet. Op deze 
manier weten wij juist waar de kennis ontbreekt en dus waar we u nog van kennis kunnen 
voorzien.  
 
Voorbeeld vraag: 
 
Mensen hebben normaal gesproken twee 2 nieren.  
(m) Waar 
(n) Niet waar 
(o) Weet ik niet 
 
U kunt nu invullen of dit volgens u 'waar' of 'niet waar' is. Weet u niet of het waar of niet 
waar is, vul dan in 'weet ik niet'. In dit geval is het juiste antwoord (a). 
 
1.   Nierziekte krijg je bij het ouder worden. Jonge mensen krijgen deze ziekte niet. 
 
  (a) Waar 
(b) Niet waar 
(c) Weet ik niet 
 
2.   Alleen directe familieleden (broers, zussen, ouders of kinderen) kunnen bij leven 
een nier doneren. 
 
  (a) Waar 
(b) Niet waar 
(c) Weet ik niet 
 
3.   Een patiënt met een nierziekte kan hoge bloeddruk, dikke enkels en een snelle 
gewichtstoename ontwikkelen wanneer het lichaam te veel wordt belast met: 
 
  (a) Eiwit 
(b) Afvalstoffen  
(c) Water 
(d) Weet ik niet 
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4.   Peritoneaal dialyse is een vorm van dialyse om patiënten met eindstadium 
nierfalen te behandelen. Welk gedeelte van het lichaam maakt deze behandeling 
mogelijk?  
 
  (a) Het buikvlies 
(b) De blaas  
(c) Het nierbekken 
(d) Weet ik niet  
5.   Alle ziekenhuiskosten van een nierdonatie bij leven worden bij de 
ziektekostenverzekering van de ontvanger gedeclareerd en niet bij die van de 
donor. 
 
  (a) Waar 
(b) Niet waar 
(c) Weet ik niet 
 
6.   Hoe vaak per week ondergaat een hemodialysepatiënt in het algemeen een sessie 
aan het dialyse apparaat? 
 
  (a) 2‐3 
(b) 5‐6 
(c) Weet ik niet 
 
7.   Voor iemand die een nier bij leven doneert komen lange termijn 
gezondheidsproblemen na donatie niet vaak voor. 
 
  (a) Waar 
(b) Niet waar 
(c) Weet ik niet 
 
8.   Patiënten met een nierziekte mogen niet al te veel zoute voeding binnen krijgen. 
 
  (a) Waar 
(b) Niet waar 
(c) Weet ik niet 
 
9.   Een donor die bij leven een nier doneert moet jonger zijn dan 50 jaar. 
 
  (a) Waar 
(b) Niet waar 
(c) Weet ik niet 
 
10.   Nierfunctievervangende therapie is noodzakelijk wanneer de nieren nog maar 
voor 50% functioneren. 
 
  (a) Waar 
(b) Niet waar 
(c) Weet ik niet 
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11.   Doneren van een nier verhoogt het risico op het ontwikkelen van een nierziekte. 
 
  (a) Waar 
(b) Niet waar 
(c) Weet ik niet 
 
12.   Peritoneaal dialyse is een vorm van nierfunctievervangende therapie dat een 
alternatief kan zijn voor hemodialyse. Een voordeel van peritoneaal dialyse kan 
zijn: 
 
  (a) Men heeft tussen het in en uit laten lopen van de spoelvloeistof meer 
bewegingsvrijheid 
(b) De behandeling maar 1 x per week plaatsvindt 
(c) Er hoeft geen operatie aan vooraf te gaan 
(d) Weet ik niet 
 
13.   De meeste donoren die bij leven een nier gedoneerd hebben blijven 2 weken in 
het ziekenhuis na operatie. 
 
  (a) Waar 
(b) Niet waar 
(c) Weet ik niet 
 
14.   Om te worden aangesloten op de hemodialyse machine, is er een toegang tot de 
bloedbaan nodig. 
 
  (a) Waar 
(b) Niet waar 
(c) Weet ik niet 
 
15.   Chirurgische complicaties na de operatie komen vaak voor bij donoren die bij 
leven een nier gedoneerd hebben. 
 
  (a) Waar 
(b) Niet waar 
(c) Weet ik niet 
 
16.   Wanneer iemand een nierziekte heeft, dan moeten de nieren worden verwijderd, 
voordat de dialysebehandeling kan starten. 
 
  (a) Waar 
(b) Niet waar 
(c) Weet ik niet 
 
17.   Voor de behandeling van eindstadium nierfalen heeft niertransplantatie in het 
algemeen de voorkeur boven dialyse. 
 
  (a) Waar 
(b) Niet waar 
(c) Weet ik niet 
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18.   Tijdens peritoneaal dialyse wordt een vloeistof door een katheter in de buikholte 
gebracht. Wat gebeurt er daarna met de vloeistof?  
 
  (a) De vloeistof blijft in de buikholte. Na een aantal uur laat men het er weer 
uitlopen 
(b) De vloeistof blijft in de buikholte, totdat het compleet is opgenomen door 
het lichaam 
(c) De vloeistof loopt in een kunstmatige nier via een andere katheter 
(d) De vloeistof loopt in een kunstmatige nier via dezelfde katheter 
(e) Weet ik niet 
 
19.   De meeste mensen die bij leven een nier doneren, kunnen binnen 4‐6 weken 
weer sporten en aan het werk. 
 
  (a) Waar 
(b) Niet waar 
(c) Weet ik niet 
 
20.   Hoeveel uur per dag is een hemodialyse patiënt aan het apparaat aangesloten? 
 
  (a) 4‐8 
(b) 12‐16 
(c) Continu 
(d) Weet ik niet 
 
21.  Een volledige overeenkomst tussen het weefsel van de donor en de patiënt geeft 
de beste overleving.  
 
  (a) Waar 
(b) Niet waar 
(c) Weet ik niet 
 
22.  Afweeronderdrukkende geneesmiddelen worden toegediend aan 
transplantatiepatiënten ter:  
 
  (a) Voorkoming en behandeling van afstoting van de transplantaatnier. 
(b) Ter behandeling van de bloedstolling van de nieuwe nier. 
(c) Ter bescherming van de nier tegen infecties door een virus of bacterie. 
(d) Weet ik niet. 
 
23. 
 
Welke behandeling geeft de beste kwaliteit van leven? 
 
  (a) Hemodialyse 
(b) Transplantatie 
(c) Peritoneaal dialyse 
(d) Weet ik niet 
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24. 
 
Peritonitis is een infectie van het buikvlies. Dit is één van de grootste problemen 
bij patiënten met peritoneaal dialyse. 
 
  (a) Waar 
(b) Niet waar 
(c) Weet ik niet 
 
25. 
 
Nierdonatie bij leven kan van invloed zijn op de kansen van een vrouw om 
zwanger te worden. 
 
  (a) Waar 
(b) Niet waar 
(c) Weet ik niet 
 
26. 
 
Door te dialyseren raakt u bepaalde vitamines kwijt. Daarom krijgt u extra 
vitamines voorgeschreven. 
 
  (a) Waar 
(b) Niet waar 
(c) Weet ik niet 
 
27.  Nieren van mensen die bij leven doneren hebben een langere overlevingsduur 
dan nieren van een donor die overleden is.  
 
  (a) Waar 
(b) Niet waar 
(c) Weet ik niet 
 
28.  Een persoon kan geen nier missen, aangezien nieren vitale organen zijn en nodig 
zijn voor een gezond leven. 
 
  (a) Waar 
(b) Niet waar 
(c) Weet ik niet 
 
29.  De meeste verzekeringsmaatschappijen betalen de reiskosten en de 
werkgeverskosten die bij nierdonatie bij leven komen kijken. 
 
  (a) Waar 
(b) Niet waar 
(c) Weet ik niet 
 
30.  Wanneer een nier van iemand die bij leven doneert niet bij de ontvanger past, 
vervalt de optie nierdonatie bij leven. 
 
  (a) Waar 
(b) Niet waar 
(c) Weet ik niet 
 
